Meta-analysis of the relationship between cytotoxin-associated gene-A and ischemic stroke subtypes

Neural Regeneration Research

Volumn 6, Issue 1, 2011, Pages 34-40

  Yang, Xu ^a   Zhao, Xiaoli ^a   Gao, Yongjun ^a   Zheng, Zhidong ^a   Li, Jilai ^a   Li, Xinyi ^b   Niu, Xiaoyuan ^b   Su, Yingying ^c  

^a AEROSPACE CENTER HOSPITAL   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxin associated gene A; Helicobacter pylori; Ischemic stroke; Meta analysis; Subtype

Indexed keywords

CAGA PROTEIN;

ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; RELIABILITY; SENSITIVITY ANALYSIS;

EID: 79951696165     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2011.01.006     Document Type: Article

References (25)

1. Palm F, Urbanek C, Grau A. Infection, its treatment and the risk for stroke. Curr Vasc Pharmacol. 2009;7(2):146-152.
2. Park MH, Min JY, Koh SB, et al. Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke. Thromb Res. 2006;118(6):671-677.
3. Masoud SA, Arami MA, Kucheki E. Association between infection with Helicobacter pylori and cerebral noncardioembolic ischemic stroke. Neurol India. 2005;53(3):303-307.
4. De Bastiani R, Gabrielli M, Ubaldi E, et al. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter. 2008;13(4):274-277.
5. Preusch MR, Grau AJ, Buggle F, et al. Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Stroke. 2004;35(8):1800-1804.
6. Gabrielli M, Santoliquido A, Cremonini F, et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J. 2004;25(1):64-68.
7. Pietroiusti A, Diomedi M, Silvestrini M, et al. Cytotoxin-associated gene-A--positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation. 2002;106(5):580-584.
8. Majka J, Rog T, Konturek PC, et al. Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors. Med Sci Monit. 2002;8(10):CR675-684.
9. Li XH, Liu P, Yin L. The relationship between cytotoxin-associated gene-A positive helicobacter pylori strains infection and cerebral infarction. Guoji Nao Xueguan Bing Zazhi. 2007;15(6):455-459.
10. Wang YM, Bai CQ. Preliminary exploration of the association between chronic Helicobacter pylori infection and ischemic stroke. Shannxi Yixue Zazhi. 2004;33(9):779-781.
11. Liu XR. Preliminary exploration of the association between Helicobacter pylori infection and primary cerebral infarction. Zhongguo Zonghe Linchuang. 2003;19(7):614-616.
12. Higgins JPT, Sally G. Aaaessing risk of bias in included studies: Cochrane handbook for Systematic Reviews of Interventions 5.0.1 [updated September 2008].The Cochrane collaboration. http://www.cochrane-handbook.org/.
13. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute stroke. Definitions for use in a multicenter clinical trial. Stroke. 1993;24(1):35-41.
14. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.
15. Cremonini F, Gabrielli M, Gasbarrini G, et al. The relationship between chronic H. pylori infection, CagA seropositivity and stroke: Meta-analysis. Atherosclerosis. 2004;173(2):253-259.
16. Pasceri V, Patti G, Cammarota G, et al. Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am Heart J. 2006;151(6):1215-1222.
17. Zhang S, Guo Y, Ma Y, et al. Relationship between the cytotoxin-associated gene-A status of H pylori strains and cerebral infarction in European Caucasians and Chinese Han: a meta-analysis. World J Gastroenterol. 2008;14(8):1286-1292.
18. Byrne MF, Murphy JF, Corcoran PA, et al. Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells. Scand J Gastroenterol. 2003;38(10): 1023-1030.
19. Zhu YL, Zheng S, Qian KD, et al. Biological activity of the virulence factor cagA of Helicobacter pylori. Chin Med J (Engl). 2004;117(9):1330-1333.
20. De Boer OJ, van der Wal AC, Becker AE. Atherosclerosis, inflammation, and infection. J Pathol. 2000;190(3):237-243.
21. Franceschi F, Sepulveda AR, Gasbarrini A, et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation. 2002;106(4):430-434.
22. Aebischer T, Schmitt A, Walduck AK, et al. Helicobacter pylori vaccine development: facing the challenge. Int J Med Microbiol. 2005;295(5):343-353.
23. Mayr M, Kiechl S, Mendall MA, et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke. 2003;34(3):610-615.
24. Diomedi M, Stanzione P, Sallustio F, et al. Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter. 2008;13(6): 525-531.
25. Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut. 2001;48(3):287-289.